Why Is ALBEMARLE CORP (ALB) Stock Down Today?

Albemarle Corp (ALB) shares fell 4.80% to $134.75 in morning trading on Thursday, pressured by a price target cut from JPMorgan and heavy put volume. The stock opened with a 2.7% gap down from the previous close and continued lower throughout the session. The move reflects investor reaction to the revised analyst outlook and bearish options activity.

What Happened

JPMorgan lowered its price target for Albemarle to $140 from $160, signaling a reduced growth expectation for the lithium and specialty chemicals company. This adjustment came as the stock already traded at a significant discount to its 52-week high of $221.00. In addition, put volume was unusually heavy, indicating a bearish bias among traders. The stock’s intraday low of $134.21 marked a new 52-week low, a level it printed four times on August 25. The session also saw a decline in sentiment, with the 30-day average sentiment score at 56 out of 100 and the 7-day average at 48, reflecting a worsening outlook.

What The Data Shows

Albemarle’s fundamentals show a mixed picture. The company has a market cap of $16.9B and a revenue growth rate of 18.3% trailing twelve months, but its price-to-earnings ratio of 290.3 and net margin of 3.8% highlight valuation concerns. The stock’s beta of 1.32 indicates higher volatility than the broader market. Volume in the session was 0.1M shares, matching the 3-month daily average, but the heavy put activity suggests increased short-term bearish positioning. Recent insider and congressional trades include several sales by Donald J. Trump and Rep. Ro Khanna, though no purchases were reported in the last 90 days.

What To Watch

Albemarle is not scheduled to report earnings in the near term. Investors should monitor the breadth of analyst coverage and any further price target adjustments, as well as the continuation of bearish options activity.